Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1

Authors

Nicholas E. Johnson, Virginia Commonwealth University
Eugenio Zapata Aldana, Western University
Nathalie Angeard, Inserm
Tetsuo Ashizawa, Houston Methodist
Kiera N. Berggren, Virginia Commonwealth University
Chiara Marini-Bettolo, University of Newcastle upon Tyne, Faculty of Medical Sciences
Tina Duong, Stanford University
Anne Berit Ekström, Drottning Silvias Barnsjukhus

Document Type

Article

Publication Date

10-1-2019

Journal

Neurology: Clinical Practice

Volume

9

Issue

5

First Page

443

Last Page

454

URL with Digital Object Identifier

10.1212/CPJ.0000000000000646

Abstract

Purpose of reviewMyotonic dystrophy type 1 is a multisystemic disorder caused by a noncoding triplet repeat. The age of onset is variable across the lifespan, but in its most severe form, the symptoms appear at birth (congenital myotonic dystrophy) or in the pediatric age range (childhood-onset myotonic dystrophy). These children have a range of disabilities that reduce the lifespan and cause significant morbidity. Currently, there are no agreed upon recommendations for caring for these children.Recent findingsThe Myotonic Dystrophy Foundation recruited 11 international clinicians who are experienced with congenital and childhood-onset myotonic dystrophy to create consensus-based care recommendations. The experts used a 2-step methodology using elements of the single text procedure and nominal group technique. Completion of this process has led to the development of clinical care recommendations for this population.SummaryChildren with myotonic dystrophy often require monitoring and interventions to improve the lifespan and quality of life. The resulting recommendations are intended to standardize and improve the care of children with myotonic dystrophy.